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Abstract
Wepreviously showed that thioether levels in the exhaled breath volatiles of volunteers undergoing
controlled humanmalaria infection (CHMI)withP. falciparum increase as infection progresses. In
this study, we show that thioethers have diurnal cyclical increasing patterns and their levels are
significantly higher inP. falciparumCHMI volunteers compared to those of healthy volunteers. The
synchronized cycle and elevation of thioethers were not present inP. vivax-infection, therefore it is
likely that the thioethers are associatedwith unique factors in the pathology ofP. falciparum.
Moreover, we found that time-of-day of breath collection is important to accurately predict (98%)
P. falciparum-infection. Critically, this was achievedwhen the diseasewas asymptomatic and
parasitemiawas below the level detectable bymicroscopy. Although thesefindings are encouraging,
they show limitations because of the limited and logistically difficult diagnostic window and its utility
toP. falciparummalaria only.We looked for new biomarkers in the breath ofP. vivaxCHMI
volunteers and found that a set of terpenes increase significantly over the course of themalaria
infection. The accuracy of predicting P. vivax using breath terpenes was up to 91%.Moreover, some of
the terpenes were also found in the breath ofP. falciparumCHMI volunteers (accuracy up to 93.5%).
The results suggest that terpenesmight represent better biomarkers than thioethers to predictmalaria
as theywere not subject tomalaria pathogens diurnal changes.
Introduction
Efforts to control malaria require accurate and reliable
diagnostic methods. Although historically microscopy
has been the most common way to diagnose malaria,
by 2014, rapid diagnostic tests (RDTs) accounted for
71% of all diagnostic testing for suspected malaria [1].
RDTs detect a number of protein biomarkers that the
malaria parasite releases into the bloodstream, includ-
ing histidine rich protein 2 (HRP2) and lactate
dehydrogenase. Unfortunately, RDTs are not suffi-
ciently sensitive to detect Plasmodium parasites at
low levels of parasitemia, when infected individuals
can act as reservoirs for ongoing malaria transmission
[2]. As well, the recent emergence of P. falciparum
parasites with partial or complete deletion of the
pfhrp2 gene has led to the worrying occurrence of
false-negative RDT results with potentially clinically
significant adverse health effects [3–7]. For these
reasons, new diagnostic modalities are therefore
required.
Recently, we identified volatile biomarkers of
Plasmodium falciparum infection in the breath of
volunteers undergoing a controlled human malaria
infection (CHMI) using the induced blood stage infec-
tion model (IBSM) [8]. The levels of four sulfur-com-
pounds in the volunteers’ breath consistently rose over
the course of the infection and dropped following
treatment. These changes in thioether levels were
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films became positive or the volunteers became symp-
tomatic. Furthermore, we noted cyclical increases and
decreases in thioether levels imposed on the general
trend. However, the low frequency of sampling pre-
vented precise determination of the period of the
cycle.
The cyclical nature of thioether production was a
novel observation consistent with general findings
about diurnal variations in levels of volatile organic
compounds (VOCs) in exhaled breath. Investigation
and understanding of temporal patterns in breath
volatiles are important to develop novel diagnostic
tools and tomaximize the efficacy and safety of new or
existing drugs [9]. Earlier studies have shown that the
levels of the abundant endogenous breath VOCs, acet-
one and isoprene, increase overnight and decline dur-
ing the day [10]. Sinues et al [11] monitored diurnal
changes in exhaled breath volatiles (EBV) and found
that, for example, a compound characterized by an ion
with the mass to charge ratio (m/z) of 211 increased
steadily during the morning, reached a maximum
shortly after lunch, and declined during the late after-
noon. In contrast, levels of another compound with
m/z=199 declined progressively from morning to
afternoon. More recently, Martinez-Lozano et al [12]
studied variations in levels of breath volatiles in three
healthy individuals during total sleep deprivation,
using secondary electrospray ionization mass spectro-
metry. They found 111 features in the breath of indivi-
duals, of which 36%–39% showed significant diurnal
variation in at least one individual. Although the study
did not unambiguously identify compounds, it
demonstrated sizable time-of-day variations in breath
metabolite levels and highlighted the possible sig-
nificance of time of day variation when assessing EBV
as biomarkers of disease.
In this study, we investigated the periodicity of
changes in thioether levels in exhaled breath of volun-
teers undergoing CHMI with Plasmodium falciparum
and P. vivax and compared the results with breath
volatiles levels in uninfected volunteers. We also sear-
ched for additional novel breath biomarkers in the
exhaled breath of volunteers undergoing CHMI with
either Plasmodium falciparum or P. vivax species,
using an untargeted approach. In addition to the sig-
nificance of the discovery of novel breath biomarkers
for malaria, understanding diurnal cycles in exhaled
breath is important for designing optimal breath sam-
pling strategies for breath-based diagnosis.
Methods
CHMI trials
P. falciparum andP. vivaxCHMI trials were conducted
as previously described [13, 14]. Separate studies were
undertaken to test the effectiveness of antimalarial
agents against P. falciparum and P. vivax, the results of
which (including parasitaemia after treatment) will be
reported elsewhere. The antimalarial drugs used were
MMV 390048 for P. falciparum trial and OZ439 for
P. vivax trial. Written informed consent to participate
in the breath analysis arm of the study, in addition to
the drug trial, was received from participants in the
study. Trial were registered in ClinicalTrials.gov with
identifier number: NCT02783833 for the P. falciparum
trial and NCT02573857 for the P. vivax trial. Descrip-
tions of the clinical trials, ethics approvals and
polymerase chain reaction (PCR)method for quantifi-
cation of P. falciparum and P. vivax parasitaemia
[13, 15] are presented in supplementary material S2.1
is available online at stacks.iop.org/JBR/12/046014/
mmedia.
Exhaled breath collection
CHMI and healthy control volunteers breathed
through a cardboard mouthpiece connected to a
chamber. The chamberwas then attached using tubing
to a 3-L SamplePro FlexFilm sample bag (SKC Inc,
Pennsylvania). The volunteers were asked to take a few
deep breaths and on the final breath in to undertake a
small exhalation using a short ‘ha’ expiration, pause,
and during the pause, put the cardboard tube between
the lips and continue the exhalation as far as they
could, comfortably. This process was designed to
selectively collect the later portion of the exhaled
enriched alveolar air. Neither a nose clip nor VOC
filter were used. Breath from the bags was transferred
to a sorbent tube as previously described [8]. Breath
samples were collected from each volunteer for up to
10 days for the P. falciparum trial and for up to 15 days
for the trial P. vivax. Breath collection time points are
detailed in supplementary table 1. For healthy con-
trols, we recruited eight participants. Each participant
provided: four breath samples containing at least 1 L
of breath daily at the following times: in the morning
(around 7:00), 11:00, 15:00 and 19:00. Samples were
collected from all participants for three consecutive
days. Longer period of breath collection per partici-
pant was not possible due to logistical limitations at
the time the experiments were carried out total
number of samples collected was 96=8 volun-
teers×3 days×4 time points. To account for day
effect and allow better comparison with infected
samples that were collected over a longer period of
time (10 and 15 days), the healthy control samples
were collected over a period of 3 weeks, i.e. three
volunteers in Week 1 and Week 2 and two volunteers
inWeek 3 (see supplementary tables 1(B) and 1(C) for
details).
GC-MS analysis of breath samples
Breath samples were analyzed using quadrupole time
of flight GC-MS (7890B series, Agilent Technologies).
Volatiles were thermally desorbed from the sorbent
tubes (Unity2, Markes International) and chromato-
grams were analyzed using the Mass Hunter
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Qualitative analysis software. Deconvolution was used
to identify compounds. Ion extraction was used to
calculate the area under peak for each thioether. In
addition, chemical standards were used to confirm the
identities of compounds. Detailed description of gas
chromatography mass spectrometry and subsequent
analysis of the captured breath samples can be found
in supplementarymaterial S2.2 and S2.3.
Statistical analysis
Fold change analysis
We used fold change (FC) as a measure to describe
how much the mean level of a breath VOC changes
between healthy and malaria-infected individuals in
samples collected at similar time points in both data
sets. FC was also used to describe changes in VOC
levels between an original and subsequent measure-
ment within the same data set. We presented the fold
change as a ratio between the two levels being
calculated. To test the null hypothesis that FC=1,
which implies that the two means being compared are
equal, the Mann–Whitney test (nonparametric test)
was used.Wedefine a statistically significant difference
inmeans if the p-value is less than 0.05.
Multicomparison test
In this work, we applied t-tests (with Bonferroni
correction; 95% confidence interval) to the thioether
levels of the healthy controls in order to find if there
were changes between paired time of day samples. The
Bonferroni correction is used to reduce the chances of
obtaining false-positive results (type I errors) when
multiple pairwise tests are performed on a single set of
data. T-tests were performed using GraphPad Soft-
ware (version 7.03).
Machine learning classification of thioether levels in
CHMIP. falciparum data and healthy controls
Machine learning algorithms are potentially able to
identify patterns in data that are not obvious to human
inspection, due to the size and complexity of the data.
For example, machine learning has been shown to
perform well in predicting the recurrence of lung
cancer or patient prognosis [16]. However rigorous
efforts are necessary to identify suitable data features
and to avoid overfitting when developing machine
learning-based predictors [17].
In this work, support vector machine (SVM) [18]
and k-nearest neighbor (k-NN) [19]machine learning
algorithms were used to test if the EBV data can sup-
port classification, i.e. is it possible to correctly classify
infected and non-infected volunteers? We present
results using linear SVML and kNN (k =3) algo-
rithms. Other parameters, kNN k =5 (as the total
number of samples were 7) and SVMR (radial), gave
similar results to k=3 and can be seen in supplemen-
tary data. SVM was performed using the open source
software LIBSVM [20]; KNN and feature selection
were performed using in-house software written in
MATLAB.
To perform classifications, only breath samples
collected at 19:00 from P. falciparum volunteers were
used. This was done because samples collected at 19:00
had elevated levels of the thioethers in P. falciparum
CHMI. Twenty three breath samples from heathy
controls were available to construct classifications
(8 volunteers× 3 days at 19:00; with one missed sam-
ple). Classification was done using five random sub-
sets of data each containing seven (out of 23) healthy
samples. This was done to ensure the resultant data is
balanced (i.e. similar number of samples in each class).
We report here the mean results for the five sets. Full
results are shown in supplementary data.
Leave-one-out cross-validation was used to train
and test classifiers. The full data set was partitioned
into N pairs of a training set (of N− 1 data samples)
and a test set (of the remaining 1 data sample). This
process was repeated N times to cover each data point
in the data set, once only.
Hypothesis test for classification
A statistically significant classification result is one
where we can reject the null hypothesis that the
biomarkers present no information about infection
status. The null hypothesis in classification is where
the classifier is operating at chance. If a classifier is
operating at random, then we expect the accuracy to
be on average r/N, where r is the number of samples in
the class with the highest number of samples in the
data set [21]. The p-value under the null hypothesis for
y instance of correctly labeled samples is P(Xy),
where X is a random variable with binomial distribu-
tion with N samples, and probability of success r/N.
We define a statistically significant classification accur-
acy if the p-value is less than 0.05.
The accuracy of the test is defined as the ability to
differentiate the infected samples and healthy controls
correctly using the thioethers. Sensitivity and specifi-
city of the test are also calculated here and they refer to
the ability of the test to determine the infected samples
correctly (sensitivity) and healthy controls correctly
(specificity).
Feature selection for untargeted search of biomarkers in
P. vivax trials
We took an automated, machine learning approach to
search for volatiles associated with the pre-treatment
course of infection in the P. vivax cohort. First, the
GC-MS data from the P. vivax CHMI trial was pre-
processed in the following steps: (1) normalization, (2)
baseline correction, (3) peak detection, and (4) peak
alignment. A full description of the method can be
found in supplementary data S2.5. After this process
was completed, we calculated the mutual information
(MI) [22, 23] between each ‘feature’ (unique combina-
tions of a specific value of mass to charge ratio (m/z)
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and the GC retention time (RT)) with the time course
(i.e. stage of the infection).
Machine learning classification of infected cases and
healthy controls using biomarkers found through
untargeted search
In the same way as the thioethers, we used SVM and
kNN machine learning algorithms to test if the data
can support a classification. We present results using
linear SVML and kNN algorithms value of k=3 for
both P. falciparum and P. vivax CHMI. Other para-
meters, kNN k>3 and SVMR (radial), gave similar
performance and can be seen in supplementary data.
To perform classifications, we used all breath samples
collected from Day 6 after infection until just before
the antimalarial drug was given, this resulted in seven
time points for P. falciparum and six time points for
the P. vivax data. A total 48 data points was available
for classification in each trial.
A total number of 95 breath samples were available
from healthy controls to construct the classifications
(8 volunteers×3 days×4 time points; 1 lost sample).
We randomly sample the full data set five times and each
data set contains 48 samples. This was done to ensure
data sets with balanced number of samples in both infec-
ted and control classes andmake sure that the results are
not due to random sampling in the subset.We then per-
formed classification on each of the five sub-sets and the
average results are discussedhereafter.
We used the same cross-validation procedures and
test for statistical significance on new biomarkers
found through untargeted search (terpenes) as for the
thioether data.
We also trained the classifiers using the terpene
data (48 Pf versus 48 controls) and used it to classify
the P. vivax and healthy data (48 samples for P. vivax
and the remaining 47 healthy data not included in the
training data set). Conversely, we trained the classifi-
cation on P. vivax and healthy data and used these to
classify the P. falciparum and healthy data. This was
done to guard against overfitting of data. Classifica-
tions were performed for those compounds whose
identity was confirmed by standards.
Chemicals
Allyl methyl sulfide (HMDB31653) was purchased from
Sigma-Aldrich (Belgium) and 1-methylthio-propane
(HMDB61871) from ABCR GmbH & Co (Karlsruhe,
Germany). (E)-1-methylthio-1-propene (HMDB59843)
and (Z)-1-methylthio-1-propene (HMDB61876) were
synthesized byAdvancedMolecular Technologies Pty ltd
(Melbourne,Australia).
Synthetic standards of the following terpenes:
α-terpinene (HMDB36995), terpinolene (HMDB36994),
m-cymene (HMDB37051) were purchased from Sigma-
Aldrich (Belgium). Limonene (HMDB03375) was pur-
chased fromHoneywell Fluka (USA).
Results
Periodicity of potentially diagnostic low levels
VOCswas found in the breath ofP. falciparum
volunteers
In an IBSM study undertaken in 2016 with P.
falciparum, breath samples were collected from seven
volunteers. To better define the periodicity of changes
in the levels of thioethers compared to our previous
studies [8], we increased the frequency of breath
collection to up to four times per day at approximately
four hour intervals, during waking hours. Details of
breath collection time points can be found in supple-
mentary table 1.
Volunteers with P. falciparum CHMI became PCR
positive onDay 4 (95.8 h) after inoculation, and reached
the treatment threshold of>1000 parasites ml−1 on the
morning of Day 8 (190.7 h after inoculation), when the
volunteers were admitted to the clinic and designated
treatmentwas commenced.
At Day 4 (95.8 h) after infection, the first measure-
ment of the day (between 7:00 and 9:00) showed that
the concentrations of three thioethers: 1-methylthio-
propane (MTP), E-1-methylthio-1-propene (MTPNE)
andZ-1-Methylthio-1-propene (MTPNZ), was approxi-
mately ten-fold lower compared with levels at Day 1
(baseline). This difference was statistically significant at
p=0.003.Thereafter, we observed synchronized cyclical
changes in the levels ofMTP,MTPNE andMTPNZwith
a period of approximately 24 h. Compared to the lowest
MTPNZ level (95.8 h after infection), the changes in
MTPNZ concentration reached a significant (p=0.001)
87-fold increase (95% CI: 35.15–454.16) about the time
the infection became symptomatic (figure 1). There was
a similar overall increase in the amplitudes of the varia-
tions in concentrations of MTPNE and MTP (supple-
mentaryfigure 1).
On Day 8 (190.7 h), after volunteers were treated
with an experimental antimalarial that contained no
sulfur atoms, two different patterns were observed
in the levels of thioethers: (1) one cycle of increase
and decrease with a maximum ∼14 h after drug
administration for MTP and MTPNE, followed by a
steady decrease in levels (supplementary figure 1);
(2) two cycles of increase and decrease with maxima
reached at ∼14 and at ∼38 h after drug administra-
tion, was observed forMTPNZ (figure 1). Cycle peri-
ods were between approximately 19 and 24 h. The
pattern of changes for each of the thioethers, in
most of the volunteers, was similar (supplementary
figure 2).
To determine whether the synchronized cyclical
change in the levels of thioethers in EBV is unique to
individuals infected with P. falciparum, breath samples
of healthy individuals were collected and analyzed.
Thioether levels were measured in eight healthy
volunteers four times a day (at approximately 7:00,
11:00, 15:00 and 19:00). The results showed that the
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concentrations of the thioethers rose and fell by a fac-
tor of four over the course of the day. The lowest level
of thioethers in the breath of volunteers was at 11:00
(supplementary figure 3). A multicomparison test
(Bonferroni; 95% confidence interval) revealed that,
for MTPNZ, measurements at 11: 00 had significantly
lower mean compared to measurements at 15:00
(p =0.0028) and 19:00 (p =0.028). For MTP and
MTPNE there were significant differences (p<0.05)
between the ‘morning’ (7:00) and ‘before lunch’
(11:00)measurements. The concentration of AMS did
not change significantly over the course of the day. Full
results of the comparisons can be found in supple-
mentary table 2.
In order to compare P. falciparum data with heal-
thy controls, we calculated mean levels of the com-
pound found for all 8 healthy control samples over the
three days of analysis, this means n=24 samples
(8 volunteers×3 days) at each time point. The diur-
nal cycle is repeated over the duration of the IBSM
trial, and the collection time matched to collections
from theP. falciparum-infected subjects (figure 1).
Thioether concentrations in the EBV of healthy
individuals showedmuch lower diurnal variation than
in P. falciparum-infected volunteers. The peak magni-
tudes of volatiles did not approach those seen at com-
parable time points of the P. falciparum trials (figure 1
and supplementary figure 1). For example, for
MTPNZ, there is a 27-fold increase (95% CI:
11.83–63.45) in the means of the MTPNZ concentra-
tion in IBSM volunteers, compared to healthy con-
trols. The difference is statistically significant at
p<0.001. Fold change and significance for all other
thioethers is shown in supplementary table 3. This
result supports the hypothesis that both the cycling
and elevation in concentration of thioethers in EBV is
specific to infectionwithP. falciparum.
We also investigated whether there was a relation-
ship between thioether levels and parasitaemia levels.
The higher frequency of sampling in this study com-
pared to our previous study revealed that the cyclical
changes in the levels of thioether have a period of 24 h.
Parasitaemia cycles every 48 h. Moreover, para-
sitaemia changes are out of phase with the thioether
levels. We found no direct relationship between the
levels of the thioethers and parasitaemia. In the future,
we aim to build machine learning regression models
that can predict this intricate changes of both para-
sitaemia and breath volatiles.
Highpredictive value of thioethers in EBV
Although thioether levels in the P. falciparum volunteers
are, on average, elevated they drop to levels close to those
ofhealthy volunteers every24 h (figure2(A)). If, however,
comparisons are made 12 h after the first sample of the
day is collected (i.e. between 19:00 and 21:00), at the peak
of the thioether evolution, there is an up to 27-fold
increase (95% CI: 11.83–63.45) in the means of the
MTPNZ in P. falciparum-infected volunteers compared
to healthy controls. Similar differences were observed for
MTPandMTPNE (supplementaryfigure 1).
Based on this observation, we tested the hypothesis
that there is significant difference between malaria-
infected groups and healthy controls using one or
more of the target thioethers, in samples collected
between 19:00 and 21:00. The quality of this test was
limited by the small size of the data set (N=7).
The robustness of the target thioethers to dis-
criminate between malaria-infected groups and con-
trols, was evaluated by two standard classification
algorithms from the field of machine learning: a SVM
and kNN (described in supplementary data S2.5). The
classification was considered statistically significant
when the accuracy was greater than 71.4% (10/14
samples), i.e. 95% confidence interval level.
Figure 1.Time course ofmean levels ofMTPNZ forP. falciparum IBSM trials (N=7), healthy controls (N=8) and parasitaemia.
P. falciparum infectionwas initiated immediately after the time zero breath sample. The red vertical dotted line represents the time
when antimalarial treatmentwas administered in theP. falciparum trial. The healthy control data shows themean levels of the
compound found at that time of day, derived from three consecutive days ofmeasurements. The diurnal cycle is repeated over the
duration of the IBSM trial, and the collection timematched to collections from theP. falciparum-infected subjects. Figure showsmean
(SEM). SEM is used as ameasure of precision for the estimatedmean. Blue asterisks denote sampling times between 19:00 and 21:00.
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For the infected samples, we used those collected
at night (i.e. 20:00±1 h) for Day 5 (131 h), Day 6
(155 h) and Day 7 (179 h) after infection. For healthy
samples, we generated data sets from randomly selec-
ted samples from the healthy control subjects at simi-
lar time points to the malaria-infected participants.
This was done because there were a larger number of
sampling time points available for healthy controls
N=24 (8 volunteers, repeated over 3 days) than for
CHMI participants (N=7) at each collection time.
Moreover, the healthy sample set contains multiple
breath samples from the same person, which was not
the case in infected samples and could potentially bias
the result in a leave-one-out cross-validation. Details
of the random selection can be found in methods
section.
At Day 5 (131 h) of infection, when themean para-
sitaemia was 0.2(±0.05) parasites μl−1, none of the
thioethers yielded classification accuracies above the
significance level value (i.e. 71.43% at p =0.05),
meaning that there is no significant difference between
malaria-infected groups and healthy controls at this
level of parasitaemia (figure 2(B) and supplementary
figure 4 and supplementary table 3(A)). At Day
6 (155 h after infection), when mean parasitaemia was
6.3(±1.3) parasites μl−1, two out of the eight tested
classifications showed significant differences between
the two groups. These two were AMS with classifica-
tion accuracy of 75% and MTPNE with 80%, accur-
acy. AMS and MTPNE had specificities of 80% and
88.6% respectively and both compounds had sensitiv-
ities of 71.4% (supplementary tables 4(A) and (B)).
At Day 7 (179 h) of infection, when the subjects
were still asymptomatic and parasitaemia below the
level detectable by microscopy (mean parasitaemia of
8.4(±1.6) parasites μl−1) analysis of MTP, MPTNE
andMPTNZ levels resulted in classification accuracies
between 91% and 98%, which are consistent with the
data shown in figure 2(B) and supplementary figure 4.
AMS seems to have no predictive value (supplemen-
tary table 4(A)). MTP and MPTNZ achieved a diag-
nostic sensitivity of 100%. The sensitivity using
Figure 2. (A)Extract of time course ofmean levels of (Z)-1-methylthio-1-propene forP. falciparumCHMI trials (N=7) (+) and for
healthy controls (N=8) (Δ). The healthy control data shows themean levels of the compound at the specified time of day andwere
derived from three consecutive days ofmeasurement. The diurnal cycle is repeated over the duration of the CHMI trial and the
collection timematched toCHMI collections. Figure showsmean(sem). Arrows indicate the peak of the compoundwhich
corresponds to 12 h after thefirst sample of the day is collected (i.e. between 19:00 and 21:00). Green asterisks indicate sampling times
between 7:00 and 8:00. (B)Comparisons ofmean (Z)-1-methylthio-1-propene levels for P. falciparum (N=7)CHMI trial (+) and
healthy controls (N=8) (Δ) for samples collected between 19:00 and 21:00. For theCHMI trial, breath samples were collected at
131 h (Day 5), 155 h (Day 6) and 179 h (Day 7) after infection. Values above red symbols represent the average parasitaemia (parasites
μl-1) at each breath collection time point.
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MTPNE was 82.9%. The best specificity was achieved
with MPTNE (100%) while MTP and MPTNZ
showed 97.1% and 88.6% sensitivity, respectively.
Together the compounds performed well in measur-
ing true positive and true negative samples when para-
sitaemiawas 8.4 parasitesμl−1.
No thioether periodicity was observed inP. vivax
trials.
We also investigated whether cyclical increases in
thioether levels are observed in the volunteers with an
experimental P. vivax infection.
Among the eight volunteers studied in the P. vivax
IBSM study, parasitaemia was first detected by PCR on
Day 4 (95.4 h after innoculation), and peaked on the
day of treatment (Day 10 in themorning=244 h) at a
mean of 232 (±49) parasites μl−1 (figure 3(A)). The
course of parasitaemia observed is consistent with pre-
vious reports [15]. Seven of the 144 scheduled breath
samples (18 time point collections × 8 volunteers)
were not collected due to exacerbation of volunteers’
symptoms upon antimalarial treatment. The timing of
missed samples is detailed in supplementary table 1.
Before treatment, thioethers were detected in the
breath samples of subjects with experimental P. vivax
infection (figure 3(A), supplementary figure 5), but the
patterns and levels were different from those observed
in P. falciparum IBSM. (i) As the P. vivax parasitaemia
increased, the mean levels of MPTNZ, MPTNE and
MTP in EBV remained low and did not approach
those observed at comparable stages in the P. falci-
parum experiment (figure 3(B) and supplementary
figure 6). For example, for MPTNZ, there was a 4.6-
fold difference between the highest level in P. falci-
parum and the highest level in P. vivax infection.
(ii) Systematic or consistent changes in the levels of
thioethers were not observed in P. vivax volunteers
(figure 3(B) and supplementary figure 6). (iii)Nor did
the changes in levels of thioethers appear to be syn-
chronized among individuals with P. vivax infection
(supplementary figure 7). (iv) The thioethers MPTNE,
AMS and MTP in the P. vivax volunteers were, on
average, slightly above the levels of those of the con-
trols before treatment (supplementary figure 5). How-
ever, the elevation was not statistically significant and,
therefore, the thioethers could not be used to predict
diseaseP. vivax infection.
Figure 3. (A)Time course of levels ofMTPNZ in breath of participants undergoing CHMIwith P. vivax (N=8), healthy controls
(N=8) and parasitaemia levels. Blue vertical dotted line represents the timewhen experimental antimalarial was administered. The
healthy control data shows themean levels of the compound found at the specified times of day, derived from three consecutive days
ofmeasurements. The diurnal cycle is repeated over the duration of the IBSM trial, and the collection timewasmatched to collections
from theP. vivax-infected subjects. Figure showsmean(sem). (B)Comparisons ofmean ofMTPNZ thioether levels for P. falciparum
(N=7) andP. vivax (N=8)CHMI trials. Both infectionswere initiated immediately after the baseline breath sample, taken at time
zero. Red (P. falciparum) and blue (P. vivax) vertical dotted lines represent the timeswhen the treatmentwas administered. Figure
showsmean(sem).
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Several terpeneswere identified in the breath of
P. vivax andP. falciparum infection
In the absence of a notable thioether signal in P. vivax
infection, we initiated an untargeted search for other
volatiles associated with the course of P. vivax infec-
tion. A number of EBV features, i.e. unique combina-
tion of specific values of mass to charge ratio (m/z)
and GC RT, were found to be associated with disease
progression. Some features identified as informative
shared similar retention times and were identified as
fragments from the same compound. In total, seven
potential volatile biomarkers for P. vivax infection
(table 1) were identified. Four of these volatiles were
fully identified using standards and shown to be
terpenes, namely: α-terpinene, m-cymene, limonene
and terpinolene. Three other volatiles could not be
identified.
Alpha-terpinene, m-cymene, limonene, terpino-
lene, ‘unknown 1’ and ‘unknown 2’ shared similar pat-
terns of variation over the course of P. vivax infection
and their levels rose as the infection progressed. Three
noticeable increases and decreases were observed, with
the largest peak 12 h after treatment, but we did not
observe a regular periodicity (figure 4(A) and supple-
mentary figure 8). It is important to note that we
observed neither elevation nor cycling of well-known
breath volatiles including isoprene and hexanal (sup-
plementary figure 9 and supplementary table 5).
We are unaware of previous reports of an associa-
tion between breath terpenes and P. vivax infection.
Although it is not possible to perform in vitro culture
of P. vivax, the terpenes identified in this study are
similar to those previously reported in P. falciparum
in vitro cultures [24] and in vivo [25]. We therefore
investigated if the same terpenes present in the breath
of volunteers infected with P. vivax are also present in
breath samples of P. falciparum IBSM volunteers. We
specifically searched for the features listed in table 1
and found that alpha-terpinene, m-cymene, limo-
nene, terpinolene and ‘unknown 1’ and ‘unknown 3’
compounds were present in the breath samples. As in
P. vivax, levels of α-terpinene in P. falciparum IBSM
increased and decreased across the duration ofmalaria
infection but with no regular periodicity (figure 4(B)).
Terpinolene, ‘unknown 1’, and m-cymene reached
similar levels in breath of participants with P. falci-
parum to those observed in P. vivax. Limonene was
also present in the breath of the P. falciparum studies,
albeit at three-fold lower levels (95% CI: 2.3–3.58)
than those found in P. vivax. The levels of all terpenes
in the P. falciparum studies rose and fell in a similar
fashion to that observed in P. vivax (figure 4(B), sup-
plementary figure 10).
Other common breath volatiles such as isoprene
neither cycled nor increased over the course of P. falci-
parum-infection (supplementary figure 11). The less
abundant reference compound, hexanal, did not
increase significantly over the course of malaria infec-
tion but did show circadian cycle before drug
administration.
Machine learning methods were used to test our
hypothesis that the terpene levels are significantly dif-
ferent between the breath of malaria-infected volun-
teers and healthy volunteers. As previously described
in the methods section, SVM and k-NN classifiers
were applied to the terpene levels. For P. vivax and P.
falciparum-infected volunteers, we used all data (since
there was no obvious cycling in these biomarkers)
from Day 6 (155 h after collection) to just the time
before treatment. The parasitaemia at the peak of
infection, just before treatment, was 131 parasites μl−1
for P. vivax and 43 parasites μl−1 for P. falciparum. For
healthy controls, we used data containing 48 random
samples (seemethods section for details).
For P. vivax and healthy controls, using leave-one-
out cross-validation, all classification accuracy rates
were above the statistically significance level (i.e. 58%,
56/96 samples). The best classification was achieved
with terpinolene (91%), followed by m-cymene
(75.8%) using SVML. Both compounds showed 97.1%
specificity and 54.6% and 85% sensitivities for terpi-
nolene and m-cymene respectively. Similar results
were found with the P. falciparum-infected samples
and healthy control data. The top two compounds
with the highest classification accuracies were terpino-
lene (87.7%), followed bym-cymene (92.7%). Average
classification results for other compounds and classi-
fiers can be found in supplementary table 6 with full
results in supplementary data.
We trained the classifiers using P. vivax data and
healthy data and they were able to classify P. falci-
parum-infected versus healthy control data for
m-cymene and terpinolene, with 94% and 93%
accuracies respectively (supplementary table 6).
Although less accurate, when the classifier was trained
with P. falciparum and the control data and applied
to P. vivax data, terpinolene (79%) and m-cymene
(75%) gave statistically significant levels of correct
classification.
Untargeted search of biomarkers using P. falci-
parum data was also carried out but showed nothing of
significance thatwarranted investigation.
Table 1.Retention times (Rt) andmass to charge ratios (m/z) for the
informative features identified inGC-QTOF-MS analysis of breath
samples from volunteers infectedwith P. vivax.
Rt (min)




14.52–14.75 91, 136, 118, 89, 120,
134, 63
α-terpinene
14.80 89, 104, 134, 120 m-cymene
14.96 153 Unknown 1
15.01 92 Limonene
15.04 147 Unknown 2
17.10 132, 92, 76 Terpinolene
28.98 167 Unknown 3
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Discussions
In this study, we found that the previously reported
thioether signal is characteristic of P. falciparum. The
levels of thioethers show a pattern of cyclical variation.
Their mean levels were significantly higher in the
breath of P. falciparum IBSM volunteers compared
with breath of healthy andP. vivax IBSMvolunteers.
Our findings show that, when time of collecting
breath samples is considered, accurate prediction of P.
falciparum-infection can be achieved (98%) using the
thioethers. Although validation in field samples and in
a larger number of subjects with higher levels of para-
sitaemia is required, these results suggest that breath
thioethers show potential as a diagnostic tool to screen
individuals and detect asymptomatic cases (>8.4 para-
sites μl−1). The detection limit for infection using
these breath markers is lower than blood smear and
RDT. Although an expert microscopist can detect as
few as 5 parasitesμl−1, an averagemicroscopist detects
only 50–100 parasites μl−1, similar to RDT which can
detect between 50–100 parasitesμl−1 [26].
The diurnal cycling of breath volatiles has implica-
tions for the use of this approach to diagnose malaria,
and suggests that the sensitivity of diagnostic breath
testing may vary according to the time of day that the
sampling is undertaken. Nocturnal or early evening
breath samplingmay be required to successfully detect
falciparummalaria infection using the thioethers.
Thioethers have previously been found in the
breath and blood of healthy individuals [27, 28] and
we have now shown that their levels display a circadian
rhythm in the breath of healthy volunteers suggesting
that the compounds are of endogenous origin. More-
over, we previously established that thioethers were
undetectable in the headspace above in vitro cultures
of P. falciparum, even at high parasitaemia levels [8].
Considering these facts we hypothesize that the ele-
vated levels of thioethers in breath of volunteers with
P. falciparum are caused by the stimulation or
enhancement of endogenous human biochemical
pathways by the parasite. Cyclic elevation of thioethers
was not observed in P. vivax infection, therefore it is
Figure 4. (A)Time course ofα-terpinene abundance in the breath of CHMIP. vivax volunteers (N=8), healthy controls (N=8) and
parasitaemia. (B)Time course ofα-terpinene levels forP. falciparumCHMI trials (N=7), healthy controls (N=8) and parasitaemia.
P. vivax andP. falciparum infectionswere started immediately after the breath sample at time zero. The vertical dotted lines represent
the timewhen treatments were administered. The healthy control data shows themean levels of the compound at that the nominated
time of day, derived from three consecutive days ofmeasurement. The diurnal cycle is repeated over the duration of the IBMS trial.
The collection timematched toCHMI breath collections. Figure showsmean(sem).
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likely that the thioethers are associated with unique
factors in the pathology ofP. falciparum.
In an untargeted search for biomarkers, we found
that a rise in the level of terpenes in EBV occurs in both
P. vivax and P. falciparum infections. Terpenes in
exhaled breath: (i) increase in concentration and
cycled over the course of malaria infection, (ii) peaked
12 h after drug treatment (figure 4(A) and supplemen-
tary figure 8), (iii) showed synchrony between indivi-
duals with respect to the variations in their levels
(supplementary figure 12), (iv) included a terpene,
limonene, that has previously been reported to be
associated with P. falciparum in cell cultures [24] and
to the isoprenoid precursor (E)-4-hydroxy-3-methyl-
but-2-enyl pyrophosphate (HMBPP) produced by P.
falciparum, which indirectly triggers human red blood
cells to increase the release of monoterpenes [29].
Recently, Schaber et al [25] found that two mosquito-
attracting terpenes, α-pinene and 3-carene, were pre-
sent at significantly higher levels in the breath of chil-
dren withmalaria compared with uninfected children.
(v) The four terpenes we identified in EBV of infected
volunteers were either found at very low levels
or were absent (e.g. ‘unknown 1’ and ‘unknown 2’
compounds) in the breath of healthy volunteers
(figure 4(A) and supplementary figure 8). When pre-
sent in breath of healthy individuals, terpenes showed
no significant diurnal changes (supplementary figure
13). (vi) The infection status could be predicted, using
a single terpene (SVML classifier), with up to 92% acc-
uracy for P. falciparum and 91% forP. vivax.
Terpenes like α-pinene and limonene, were found
specifically and consistently in the headspace of para-
site-infected red blood cells [24]. The significance of
this finding was that apicomplexan parasites, includ-
ing Plasmodium species, contain an apicoplast (an
organelle with a similar endosymbiotic evolutionary
origin to plant chloroplasts) that synthesizes iso-
prenoids via the methylerythritol phosphate (MEP)
pathway. This pathway is not present in animals. Iso-
prenoids serve multiple biochemical functions,
including growth and development [30], asmembrane
components, and as hormones [31]. Terpenes belong
to the isoprenoid class. As postulated by Kelly et al
[24], Plasmodium falciparum parasites might utilize
the MEP pathway to produce terpenes. It has been
recently been shown that two specific terpenes (α-
pinene and 3-carene) are elevated in the breath of chil-
dren presenting with P. falciparum malaria to a clinic
inMalawi [25].
There have been a number of studies on changes in
human odor due to malaria infection and how infec-
tion can affect mosquito behavior [32, 33]. One study
examined the foot odor of CHMI volunteers (with low
densities of asexual parasites and no gametocytes), the
carbonyls 2- and 3-methylbutanal, 3-hydroxy-2-buta-
none and 2-ethyl hexanoic acid were altered during
and after CHMI [32]. Recently, Robinson et al [33]
found that higher levels of six compounds, most of
them aldehydes, were exhaled from children’ socks
during natural malaria infection compared to the
socks of parasite-free individuals. These aldehydes
were positively correlated with overall parasite density
and the blend of aldehydes increased the attractiveness
to the malaria vector Anopheles coluzzii when tested
with a synthetic mosquito lure. Moreover, another
recent study also documented volatile changes in the
skin (foot and arm) from children with asymptomatic
and symptomatic malaria infections [34]. They found
a set of malaria diagnostic volatiles coming from
diverse chemical families, including aldehydes. None
of these studies found the thioethers nor the terpenes,
suggesting that parasite densities and developmental
stage might induce a range of physiological changes in
the human body that affect breath and body odor in
variedways.
The data presented in this paper show diurnal
cycling of thioethers in P. falciparum infection and
represent the first evidence that EBV terpene levels
increase in human P. vivax infection. These findings
need to be tested in thefield. If confirmed, terpenesmay
be more convenient as a malaria biomarker because of
their lack of diurnal variation. However, the prediction
power of using terpenes and thioethers should also be
considered. It would be desirable also to understand the
impact of mixed infections on the levels of both thioe-
thers and terpenes inhumanbreath.
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